Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICP-488 in Moderate-to-Severe Plaque Psoriasis
CTR20232558Phase 2Completed
- Sponsor
- InnoCare Pharma
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of icp-488 in plaque psoriasis, sponsored by InnoCare Pharma. Started Aug 2023; status: completed.
02
Drugs
icp-488
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20232558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232558.